c-Met identifies a population of matrix metalloproteinase 9-producing monocytes in peritumoural stroma of hepatocellular carcinoma

Macrophages (Mϕ) are prominent components of solid tumours and exhibit distinct phenotypes in different microenvironments. Previously, we found that tumours could alter the normal developmental process of Mϕ to trigger transient activation of monocytes in the peritumoural stroma of human hepatocellu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pathology 2015-11, Vol.237 (3), p.319-329
Hauptverfasser: Zhao, Lan, Wu, Yan, Xie, Xu-Dong, Chu, Yi-Fan, Li, Jin-Qing, Zheng, Limin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Macrophages (Mϕ) are prominent components of solid tumours and exhibit distinct phenotypes in different microenvironments. Previously, we found that tumours could alter the normal developmental process of Mϕ to trigger transient activation of monocytes in the peritumoural stroma of human hepatocellular carcinoma (HCC). In the present study, we showed that a fraction of monocytes in the peritumoural stroma, but not in HCC cancer nests, expressed surface c‐Met molecules. Monocytes exposed to tumours strongly expressed c‐Met proteins with kinetics similar to their activation status, and significant correlations were found between c‐Met levels and HLA‐DR expression on tumour‐infiltrating monocytes. NF‐κB‐mediated autocrine TNF‐α stimulated the expression of c‐Met on activated monocytes, and by interacting with its ligand hepatocyte growth factor (HGF), c‐Met increased the motility and matrix metalloproteinase (MMP) 9‐producing capacity of tumour‐associated monocytes. The intensity of c‐Met expression on tumour‐infiltrating monocytes was associated with high mortality and reduced survival of patients with HCC. Therefore, the expression of c‐Met on activated monocytes/Mϕ may represent a novel mechanism by which a tumour actively and precisely regulates the distribution and functions of these cells to facilitate disease progression. Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
ISSN:0022-3417
1096-9896
DOI:10.1002/path.4578